Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Maria Malfitano

Showing results (21-30 of 71) with videos related to

Pageof 8
Sort By:
Molecular Pharmacology|July 11, 2006
The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits human breast cancer cell proliferation through a lipid raft-mediated mechanismDaniela Sarnataro, Simona Pisanti, Antonietta Santoro, et al.
Pharmacological Research|November 30, 2011
The CB1 receptor antagonist rimonabant controls cell viability and ascitic tumour growth in miceAnna Maria Malfitano, Chiara Laezza, Mario Galgani, et al.
Anti-Cancer Agents in Medicinal Chemistry|February 22, 2008
Biological and pharmacological roles of N6-isopentenyladenosine: an emerging anticancer drugMaurizio Bifulco, Anna Maria Malfitano, Maria Chiara Proto, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|March 17, 2009
Use of cannabinoid receptor agonists in cancer therapy as palliative and curative agentsSimona Pisanti, Anna Maria Malfitano, Claudia Grimaldi, et al.
Biochimie|February 22, 2017
Immunomodulatory properties of 1,2-dihydro-4-hydroxy-2-oxo-1,8-naphthyridine-3-carboxamide derivative VL15Anna Maria Malfitano, Chiara Laezza, Simone Bertini, et al.
European Journal of Pharmacology|May 10, 2026
SAHA induces immunogenic cell death in triple negative breast cancer cells and its efficacy is enhanced by SOCS3 functional replacementGiuliano Castellano, Candida Bucciero, Alessia Cugudda, et al.
Cancers|November 17, 2019
G-Quadruplex Binders Induce Immunogenic Cell Death Markers in Aggressive Breast Cancer CellsSarah Di Somma, Jussara Amato, Nunzia Iaccarino, et al.
Mutation Research. Reviews in Mutation Research|June 7, 2025
Nutritional bioactive compounds with beneficial effects for multiple sclerosis: Potential implication of G-Quadruplexes?Anna Maria Malfitano, Giuliano Castellano, Alessandra Croce, et al.
Cells|August 26, 2022
Combination of <i>dl922-947</i> Oncolytic Adenovirus and G-Quadruplex Binders Uncovers Improved Antitumor Activity in Breast CancerFabiana Napolitano, Sarah Di Somma, Giuliano Castellano, et al.
Molecular Neurobiology|February 17, 2026
The Diet-Multiple Sclerosis Connection: Oxidative Stress and Emerging MechanismsCandida Bucciero, Alessandra Croce, Giuliano Castellano, et al.
Pageof 8

Showing results (21-30 of 71) with videos related to

Sort By:
Pageof 8
Molecular Pharmacology|July 11, 2006
The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits human breast cancer cell proliferation through a lipid raft-mediated mechanismDaniela Sarnataro, Simona Pisanti, Antonietta Santoro, et al.
Pharmacological Research|November 30, 2011
The CB1 receptor antagonist rimonabant controls cell viability and ascitic tumour growth in miceAnna Maria Malfitano, Chiara Laezza, Mario Galgani, et al.
Anti-Cancer Agents in Medicinal Chemistry|February 22, 2008
Biological and pharmacological roles of N6-isopentenyladenosine: an emerging anticancer drugMaurizio Bifulco, Anna Maria Malfitano, Maria Chiara Proto, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|March 17, 2009
Use of cannabinoid receptor agonists in cancer therapy as palliative and curative agentsSimona Pisanti, Anna Maria Malfitano, Claudia Grimaldi, et al.
Biochimie|February 22, 2017
Immunomodulatory properties of 1,2-dihydro-4-hydroxy-2-oxo-1,8-naphthyridine-3-carboxamide derivative VL15Anna Maria Malfitano, Chiara Laezza, Simone Bertini, et al.
European Journal of Pharmacology|May 10, 2026
SAHA induces immunogenic cell death in triple negative breast cancer cells and its efficacy is enhanced by SOCS3 functional replacementGiuliano Castellano, Candida Bucciero, Alessia Cugudda, et al.
Cancers|November 17, 2019
G-Quadruplex Binders Induce Immunogenic Cell Death Markers in Aggressive Breast Cancer CellsSarah Di Somma, Jussara Amato, Nunzia Iaccarino, et al.
Mutation Research. Reviews in Mutation Research|June 7, 2025
Nutritional bioactive compounds with beneficial effects for multiple sclerosis: Potential implication of G-Quadruplexes?Anna Maria Malfitano, Giuliano Castellano, Alessandra Croce, et al.
Cells|August 26, 2022
Combination of <i>dl922-947</i> Oncolytic Adenovirus and G-Quadruplex Binders Uncovers Improved Antitumor Activity in Breast CancerFabiana Napolitano, Sarah Di Somma, Giuliano Castellano, et al.
Molecular Neurobiology|February 17, 2026
The Diet-Multiple Sclerosis Connection: Oxidative Stress and Emerging MechanismsCandida Bucciero, Alessandra Croce, Giuliano Castellano, et al.
Pageof 8